← Back to Search

Procedure

Digital Monitoring for Coronary Artery Disease

N/A

Recruiting

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at University of California Davis Health

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one month, six months

Awards & highlights

Study Summary

This trial tests a telemonitoring program for patients with coronary heart disease to improve patient outcomes and satisfaction after PCI. It will measure blood pressure, LDL, revascularization, mortality, and patient satisfaction.

Who is the study for?

This trial is for patients with coronary heart disease who have undergone a procedure called percutaneous coronary intervention (PCI) and are followed up at UC Davis Health. It's not suitable for individuals who don't meet these specific conditions.Check my eligibility

What is being tested?

The study compares standard care with a telemonitoring program that includes remote monitoring, text-based follow-ups, health goals, education on using the app, and devices. The goal is to see if this reduces adverse cardiovascular events after PCI.See study design

What are the potential side effects?

Since this trial involves digital monitoring rather than medication or invasive procedures, side effects may include privacy concerns or stress from constant health tracking but no physical side effects like those from drugs or surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one month, six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one month, six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and one month, six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

average ratings on the telehealth usability questionnaire

blood pressure, systolic and diastolic

enrollment rate in cardiac rehabilitation

+3 more

Secondary outcome measures

Major adverse cardiovascular events (MACE)

lipid profile

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Discharged with LiveCare and Text Message InterventionActive Control2 Interventions

Patients receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

Group II: Discharged with Conventional CarePlacebo Group1 Intervention

Patients do not receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor

911 Previous Clinical Trials

4,709,319 Total Patients Enrolled

4 Trials studying Coronary Artery Disease

10,695 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for volunteers to participate in this scientific trial?

"Yes, the research displayed on clinicaltrials.gov substantiates that this medical experiment is actively recruiting participants. First published on November 10th 2023 and last edited 27 days later, it aims to enroll 200 subjects from 1 locale."

Answered by AI

What is the scale of the current research study?

"Correct. According to information provided on clinicaltrials.gov, this research study is currently seeking participants and has been since November 10th 2023. The trial's latest update was posted on October 27th 2023 and 200 individuals are being recruited from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events

2023. "Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06114615.

All > Coronary Artery Disease